Business & Regulation

Business & Regulation Digital Technologies

03/19/2025 | Tim Tinnel | 3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

Business & Regulation Standards & Regulation

03/19/2025 | Rob Coker | 2 min read

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Business & Regulation Trends & Forecasts

03/10/2025 | Stephanie Vine | 9 min read

We take a deep dive into key industry trends off the back of Clarivate’s Drugs to Watch 2025 report

Business & Regulation Business Practice

03/07/2025 | 7 min read

In part 2 of our roundtable discussion, thought leaders discuss what Trump could do for drug pricing and whether change is to be feared or embraced.

Business & Regulation Trends & Forecasts

03/07/2025 | Stephanie Vine | 8 min read

We speak with Clarivate about their report listing eleven key drugs to watch in 2025.

Business & Regulation Supply Chain

03/05/2025 | Juliana Maynard | 6 min read

Radiopharmaceuticals are a promising approach to cancer, but some countries are lagging behind. A collaboration hopes to change that.

Business & Regulation Business Practice

03/05/2025 | 10 min read

Biden pushed drug pricing reforms, whereas Trump is known for deregulation. What does this mean for pharma?

Business & Regulation Profession

03/03/2025 | 5 min read

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Business & Regulation Business Practice

02/28/2025 | Stephanie Vine | 2 min read

To shareholders – according to an analysis of financial reports from healthcare companies.

Business & Regulation Standards & Regulation

02/25/2025 | Stephanie Vine | 3 min read

A regulatory science push in the UK includes centres for digital transformation, AI and more.